The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
Clinical trial NCT03760458 · COMPLETED
Trial details
- NCT number
- NCT03760458
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2021-12-14
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.